Related Experiment Video
Updated: Apr 16, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
2.0K
Tumor-infiltrating dendritic cells in cancer pathogenesis
Jo Marie Tran Janco1, Purushottam Lamichhane2, Lavakumar Karyampudi3
1Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN 55906;
Journal of Immunology (Baltimore, Md. : 1950)
|March 22, 2015
Summary
Dendritic cells (DCs) are crucial in cancer immunity. Understanding how tumors suppress these immune cells offers new therapeutic strategies to enhance anti-cancer immune responses.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Dendritic cells (DCs) are key regulators of the tumor microenvironment (TME).
- Tumor-infiltrating DCs can promote anti-tumor immunity or be suppressed by malignancies.
- Tumor cells actively manipulate the TME to recruit immunosuppressive DCs.
Purpose of the Study:
- To explore the dual role of dendritic cells in the tumor microenvironment.
- To understand mechanisms of DC suppression by tumor cells.
- To identify therapeutic targets within tumor-infiltrating DCs.
Main Methods:
- Analysis of DC function in various human malignancies.
- Investigation of tumor cell strategies to alter the TME.
- Review of emerging cancer-therapeutic strategies targeting DCs.
Main Results:
- Mature, active DCs enhance anti-tumor immune responses.
- Tumor cells can suppress DC function and promote immune suppression.
- Targeting tumor-infiltrating DCs shows promise for cancer therapy.
Conclusions:
- Dendritic cells are critical players in anti-cancer immunity.
- Modulating DC function within the TME is a viable therapeutic approach.
- Further research into DC-targeting therapies may improve cancer treatment outcomes.
Related Concept Videos
02:17The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:35Cancer Cell Migration through Invadopodia
3.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
02:30Metastasis
7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K